In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
- WHO: Nigeria Not Doing Enough To End Tuberculosis on September 19, 2018 at 4:13 am
The World Health Organisation (WHO) has raised the alarm that more than a quarter of the world’s population is at risk of developing tuberculosis during their lifetime. In its latest Global ... […]
- Tuberculosis Remains as World's Deadliest Infectious Disease: WHO on September 19, 2018 at 1:37 am
Tuberculosis (TB) still remains as the world's deadliest infectious disease, despite averting about 54 million tuberculosis (TB) deaths since 2000, warned the World Health Organization (WHO). WHO, in ... […]
- 1.3bn People At Risk of Tuberculosis – WHO on September 19, 2018 at 1:13 am
The World Health Organisation (WHO) says that a quarter of the world’s population has TB infection or some 1.3 billion people, are at risk of developing TB during their lifetime. According to ... […]
- UN tuberculosis summit ‘historic opportunity’ to put response ‘back on track’: new WHO report on September 18, 2018 at 8:31 pm
New York, Sept 19 (IBNS): Countries are not doing enough to end tuberculosis – the world’s deadliest infectious disease – by 2030, warned the World Health Organization (WHO) on Tuesday, at the release ... […]
- Tuberculosis is curable. So why are so many people still dying of the disease? on September 18, 2018 at 4:57 pm
TUBERCULOSIS REMAINS the world’s most lethal infectious killer. It claims more lives than HIV/AIDS and malaria combined. TB is also a preventable, treatable, curable disease. Clearly there is an enorm... […]
- WHO: Child mortality, tuberculosis crises on track to worsen by 2030 on September 18, 2018 at 2:42 pm
Sept. 18 (UPI) --Health crises including child mortality rates and tuberculosis, already affecting millions of people, are expected to worsen by 2030, a pair of reports released Tuesday by the World H... […]
- Tuberculosis Remains World’s Top Infectious Killer, But A Turning Point May Be Near on September 18, 2018 at 10:13 am
Tuberculosis remains the world’s top infectious killer for the fourth year in a row, the World Health Organization said Tuesday. Despite TB’s lock on the grim title, as it kills far more than HIV/AIDS ... […]
- Negotiated Deal Stands For UN Tuberculosis Declaration on September 18, 2018 at 6:27 am
IP-Watch is a non-profit independent news service and depends on subscriptions. To access all of our content, please subscribe here. You may also offer additional support with your subscription, or do... […]
- U.N. finalizes a declaration to combat the global tuberculosis epidemic on September 17, 2018 at 5:58 am
fter a protracted showdown, the United Nations has finalized a declaration to address a global tuberculosis epidemic, an effort that was repeatedly delayed this summer as the U.S. and numerous other c... […]
- Ending tuberculosis will take lower drug prices and a new, improved innovation ecosystem on September 13, 2018 at 1:45 am
he United Nations “high-level meeting” on tuberculosis will take place in less than a month and the political declaration that emerges from it will, for better or worse, shape the global response to t... […]
via Google News and Bing News